[ Numaferm raises undisclosed amount in Seed Funding ]

Numaferm has raised an undisclosed amount in Seed Funding.

Founded in 2017, Numaferm  is a biochemical company that develops a technology for peptide production in escherichia coli bacterium for the pharmaceutical industry.

The company will use the new financing for the further technological development and an accelerated market entry.

Funding  Seed
Founded  2017
Country  Germany
City  Düsseldorf, Nordrhein-Westfalen
Founder / CEO  Dr. Christian , Schwarz
Deal Size  undisclosed 
Investors  European Investment Fund
  Jürgen Schumacher
 Detlev Riesner
 High-Tech Gruenderfonds
Previous Investors  /